Physician Assistant · Indianapolis, IN
NPI
1568719060
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
355 W 16th St Ste 3200
Indianapolis, IN, 46202
Phone (317) 948-5450
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
560 services
Medicare patients, 2024
228
Average age 66
Drug cost, 2024
$4.4M
3,736 prescriptions
Company payments, 2024
$15
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John S Emmett was code 99214 (office e&m - established), 199 times for 158 patients. In total John S Emmett billed 560 services in 17 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 199 | 158 | $71.82 | $14K |
| 99213 Office E&M - Established | Office | 81 | 70 | $51.10 | $4,139 |
| 97165 PT/OT Evaluation | Office | 43 | 32 | $51.03 | $2,194 |
| 92522 Speech Therapy | Office | 41 | 30 | $55.71 | $2,284 |
| 97161 PT/OT Evaluation | Office | 34 | 26 | $45.26 | $1,539 |
| 92610 Speech Therapy | Office | 29 | 23 | $47.83 | $1,387 |
| 92524 Speech Therapy | Office | 25 | 17 | $52.87 | $1,322 |
| 97166 PT/OT Evaluation | Office | 24 | 20 | $50.21 | $1,205 |
| 97162 PT/OT Evaluation | Office | 24 | 22 | $42.38 | $1,017 |
| 97163 PT/OT Evaluation | Office | 21 | 20 | $33.55 | $705 |
| 97167 PT/OT Evaluation | Office | 17 | 16 | $48.74 | $829 |
By year: 2022 $33K for 606 services; 2023 $38K for 666 services; 2024 $33K for 560 services.
Medicare prescription drug claims, 2024
In 2024, the drug John S Emmett prescribed most often to Medicare patients was Gabapentin, with 360 prescriptions and refills. In total John S Emmett wrote 3,736 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 360 | 566 | 96 | $8,584 |
| Baclofen Generic | 356 | 656 | 96 | $10K |
| Tizanidine Hcl Generic | 165 | 296 | 36 | $3,888 |
| Riluzole Generic | 158 | 248 | 39 | $58K |
| Pregabalin Generic | 138 | 174 | 37 | $9,066 |
| Clonazepam Generic | 108 | 140 | 28 | $1,139 |
| Teriflunomide Generic | 99 | 101 | 16 | $152K |
| Topiramate Generic | 95 | 158 | 25 | $1,723 |
| Glatiramer Acetate Generic | 82 | 82 | 11 | $133K |
| Modafinil Generic | 75 | 95 | 23 | $10K |
| Amitriptyline Hcl Generic | 73 | 135 | 17 | $1,430 |
| Glycopyrrolate Generic | 72 | 96 | 20 | $4,308 |
| Solifenacin Succinate Generic | 65 | 117 | 17 | $3,631 |
| Copaxone Glatiramer Acetate | 63 | 63 | 11 | $362K |
| Fingolimod Fingolimod Hcl | 61 | 61 | Under 11 | $104K |
Brand drugs: 436 claims; generic drugs: 3,300 claims; opioid claims: 91.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid John S Emmett $15 ($15 in general payments such as food, travel and fees) from 1 company. The largest payer was Alexion Pharmaceuticals, Inc. with $15.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 1 | $15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.